Cellectar Biosciences, Inc. (CLRB)
2.71
+0.16
(+6.27%)
USD |
NASDAQ |
Apr 06, 16:00
2.70
-0.01
(-0.37%)
After-Hours: 20:00
Cellectar Biosciences SG&A Expense (TTM) : 11.48M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| EyePoint Plc | 51.70M |
| Ocugen, Inc. | 27.58M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.211B |
| Savara, Inc. | 42.06M |